Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
28 Mar 2024
Historique:
received: 01 02 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2024.285207 PMID: 38546689
pubmed: 38546689
doi: 10.3324/haematol.2024.285207
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Elisa Jacobsen Pulczynski (EJ)

Department of Haematology, Aarhus University Hospital, Aarhus, Denmark; Department of Haematology, Region Hospital Goedstrup, Herning.

Mikkel Runason Simonsen (MR)

Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Mathematical Sciences, Aalborg University, Aalborg.

Outi Kuittinen (O)

Department of Oncology, Kuopio University Hospital Cancer Center, Kuopio, Finland; Faculty of Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio.

Unn-Merete Fagerli (UM)

Department of Oncology, St Olav University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of science and technology (NTNU), Trondheim, Norway.

Martin Erlanson (M)

Department of Radiation Sciences, Umeå University, Umeå, Sweden.

Øystein Fluge (Ø)

Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.

Sirpa Leppä (S)

Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki.

Bjørn Østenstad (B)

Department of Oncology, Oslo University Hospital, Oslo, Norway.

Alexander Fosså (A)

Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B-cell Malignancies, University of Oslo, Oslo, Norway.

Mikael Eriksson (M)

Department of Oncology, Skane University Hospital, Lund, Sweden; Medical Oncology, Lund University, Lund, Sweden.

Tarec El-Galaly (T)

Department of Hematology, Aalborg University Hospital, Aalborg.

Hanne Kuitunen (H)

Cancer Centre, Oulu University Hospital, Oulu.

Karin Papworth (K)

Department of Radiation Sciences, Umeå University, Umeå, Sweden.

Maria Ljungqvist (M)

Department of Clinical Science and Education, Södersjukhuste, Karolinska Insitutet, Stockholm, Sweden; Haematology Centre, Karolinska University Hospital, Stockholm, Sweden.

Martin B Pedersen (MB)

Department of Haematology, Aarhus University Hospital, Aarhus.

Marjukka Pollari (M)

Research Programs Unit/Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; Department of Oncology, Tays Cancer Center, Tampere University Hospital, Tampere. marjukka.pollari@pirha.fi.

Classifications MeSH